Showing 81 - 90 of 197 for "Harry Elias Partnership" with applied filters
Banking and finance, Capital markets, Construction, Corporate and M&A, Dispute resolution, Intellectual property, Investment funds, Labour and employment, Pharmaceuticals and life sciences, Private equity, Regulatory, Restructuring and insolvency, Tax
Aviation and shipping, Pharmaceuticals and life sciences
Banking and finance, Competition/antitrust, Construction, Corporate and M&A, Dispute resolution, Intellectual property, Labour and employment, Restructuring and insolvency
Banking and financial services, Energy, Infrastructure
Banking and finance, Capital markets, Corporate and M&A, Dispute resolution, Energy, Infrastructure, Intellectual property, Labour and employment, Media and entertainment, Private equity, Real estate, Regulatory, Restructuring and insolvency, Tax, Technology and telecommunications
Media and entertainment, Real estate
01 April 2024 by
Rosli Dahlan Saravana Partnership (RDS) welcomed Falisa Abu Bakar as a Partner
20 March 2024 by
SSEK Acts for Tokushukai Medical Corporation Group in Major Cooperation Project in Indonesian Health Sector
15 March 2024 by
Makarim & Taira S., a leading law firm known for its commitment to nurturing top legal talent, proudly announces the appointment of Reagan Roy as its newest Partner.
05 January 2024 by
Barely a week ago on December 29, 2023, China’s legislative body passed and President Xi Jinping signed into law the newly revised Company Law, effective from July 1, 2024 (the “New Law”).
04 January 2024 by
Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.
29 August 2023 by
The Korean Ministry of Economy and Finance (MOEF) confirmed and announced the FY2023 tax law amendment proposals on July 27, 2023 (Proposals).
20 April 2023 by
The Indian pharmaceutical market is one of the largest markets in the globe, both in terms of production and consumption. Several changes have been made to the patent and competition law due to the increasing challenges in the pharmaceutical market that directly impact the profit margin of pharmaceutical manufacturers. To increase these margins, pharmaceutical product manufacturing firms employ a variety of strategies. This article investigates the concept of “product hopping” and compares it with the practice of patent evergreening.
